NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Phase II Study of JNJ-42756493 (Erdatfitinib) in Patients with Tumors Harboring FGFR Alterations

Project: Research project

Project Details

Description

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Phase II Study of JNJ-42756493 (Erdatfitinib) in Patients with Tumors Harboring FGFR Alterations
StatusFinished
Effective start/end date10/1/199/9/21

Funding

  • THE CHILDREN'S HOSPITAL OF PHILADELPHIA
  • LEIDOS BIOMEDICAL RESEARCH, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.